Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Institut de recherches cliniques de Montréal

$732,000.00

PTPN12: a key regulator of receptor-mediated signals and functions in immune cells and cancer cells

EF 2013-14

Résumé
A type of enzyme that removes phosphates from other proteins is named "phosphatase". PTPN12 is one such enzyme. It is present inside all cells. Previous work showed that PTPN12 has the key role of controlling the ability of cells to move, attach and detach. This is critical for a number of life-maintaining functions such as development of the embryo, wound healing and immune protection against microbes and cancer. New data indicate that PTPN12 is also needed for the activities of certain molecules located at the surface of the cell and known as "receptors". We have found that, as a result of this novel role, PTPN12 is essential for the ability of cells of the immune system called "macrophages" to eat and destroy cancer cells and defective cells. We and others have also determined that, through this activity, PTPN12 slows down the development of certain cancers, by controlling the ability of cancer cells to move and invade healthy tissues. This project is aimed at pursuing these new exciting clues regarding PTPN12. We trust that it will augment our knowledge of what PTPN12 does and how it does it in health and disease. Importantly, it may also lead to identification of new ways to kill cancer cells through macrophages. In addition, it may enable the discovery of new treatments to slow down the development of certain cancers.
Programme
Operating Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
291086
Name
Veillette André
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
PTPN12: a key regulator of receptor-mediated signals and functions in immune cells and cancer cells
Programtype2
Operating Grants
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$732,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Immune Cells; Phagocytosis; Phosphatase; Receptors; Signaling; Tumor Cells
Abstract
A type of enzyme that removes phosphates from other proteins is named "phosphatase". PTPN12 is one such enzyme. It is present inside all cells. Previous work showed that PTPN12 has the key role of controlling the ability of cells to move, attach and detach. This is critical for a number of life-maintaining functions such as development of the embryo, wound healing and immune protection against microbes and cancer. New data indicate that PTPN12 is also needed for the activities of certain molecules located at the surface of the cell and known as "receptors". We have found that, as a result of this novel role, PTPN12 is essential for the ability of cells of the immune system called "macrophages" to eat and destroy cancer cells and defective cells. We and others have also determined that, through this activity, PTPN12 slows down the development of certain cancers, by controlling the ability of cancer cells to move and invade healthy tissues. This project is aimed at pursuing these new exciting clues regarding PTPN12. We trust that it will augment our knowledge of what PTPN12 does and how it does it in health and disease. Importantly, it may also lead to identification of new ways to kill cancer cells through macrophages. In addition, it may enable the discovery of new treatments to slow down the development of certain cancers.
Competitiondate
201309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Veillette, André
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $732,000~ $0~